TD Asset Management Inc Has $299.87 Million Stock Holdings in Cencora, Inc. $COR

TD Asset Management Inc lifted its holdings in shares of Cencora, Inc. (NYSE:COR) by 178.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 887,846 shares of the company’s stock after buying an additional 569,305 shares during the period. TD Asset Management Inc owned about 0.46% of Cencora worth $299,870,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lido Advisors LLC raised its position in Cencora by 2.0% during the fourth quarter. Lido Advisors LLC now owns 8,956 shares of the company’s stock worth $2,880,000 after acquiring an additional 178 shares in the last quarter. WCG Wealth Advisors LLC bought a new stake in Cencora during the fourth quarter worth $8,449,000. CIBC Asset Management Inc raised its position in Cencora by 28.9% during the fourth quarter. CIBC Asset Management Inc now owns 85,355 shares of the company’s stock worth $28,816,000 after acquiring an additional 19,154 shares in the last quarter. Marble Wealth LLC bought a new stake in Cencora during the fourth quarter worth $419,000. Finally, Bridges Investment Management Inc. raised its position in Cencora by 35.6% during the fourth quarter. Bridges Investment Management Inc. now owns 2,357 shares of the company’s stock worth $796,000 after acquiring an additional 619 shares in the last quarter. 97.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on COR. Citigroup dropped their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. JPMorgan Chase & Co. boosted their target price on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Weiss Ratings cut Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Finally, Barclays increased their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $380.25.

Cencora Stock Down 0.2%

COR opened at $264.40 on Thursday. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The stock’s fifty day simple moving average is $294.84 and its 200 day simple moving average is $331.59. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a market cap of $51.44 billion, a PE ratio of 20.28, a price-to-earnings-growth ratio of 1.22 and a beta of 0.59.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora declared that its Board of Directors has approved a stock buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.